Radio: Hosts Bill Moran, Bill Handel, Bill Carroll, Patt Morrison and Michael ... Long Beach Press-Telegram On the panel will be KFI's Bill Handel and Bill Carroll, Patt Morrison of KPCC (89.3 FM), and Michael Harrison, the publisher of Talkers Magazine and former KMET (now KTWV, 94.7 FM) Sunday evening talk host. So what will Bill, Bill, Bill, Patt and Mike ...
Karen Handel resigns: Deconstructionists needed Washington Post (blog) I just read the Karen Handel resignation letter, and it's tough slogging, a bit like picking through tornado debris in search of a survivor. She's basically saying, this wasn't just my idea to defund Planned Parenthood, this was a group effort, ...
Shots - Health Blog : NPR NPR But the resignation of Karen Handel, an outspoken opponent of the reproductive health group, hasn't slowed down foes of Planned Parenthood. Even as Handel was on her way out the door, two anti-abortion groups were releasing a report intended to push ...
She The People Washington Post (blog) And well before the bloody corpse of that GOPer, Karen Handel, was dragged through the streets on Tuesday after resigning, I had slipped out of what Kathleen Parker rightly called a mob. So, too, can I see all the way to the other side of the fence on ...
Oak Park Public Library Calendar, Feb. 9 Oak Park Leaves Handel Week Program: with Carl Grapentine, 3 pm Feb. 12. Nationally-known WFMT-FM radio presenter Carl Grapentine returns to kick off Oak Park's Handel Week Festival with a free lecture on “The Magnificent Mr. Handel featuring The Oratorio, Semele.
Handel and Haydn Society conducted by Jean-Marie Zeitouni The Phoenix The Handel and Haydn Society has invited him back to lead one of the most exciting and demanding symphonies in the repertoire: Beethoven's Eroica, on a program with Beethoven's dramatic Egmont Overture and Haydn's rarely heard Symphony No. 48.
Basilea reports 2011 financials with better than expected operating results Reuters The US alitretinoin HANDEL phase III treatment and six-month relapse observation studies were completed in 2011. Topline data are expected to be available in the first quarter 2012. The filing of a US New Drug Application (NDA) for alitretinoin is ...
